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_____________________________________________________________ 
The phytochemical analysis of the root bark extracts of the Chilean 
Maytenus, M. chubutensis and M. magellanica (Celastraceae) led to the 
isolation of one phenolic nor-triterpene (1) and one diterpene with a nor-ent-
kaurene skeleton (2). In addition, four known compounds were isolated, 
among which compound 3 has been isolated for the first time from a natural 
source. Their structures were elucidated by spectroscopic methods, 
including 1D and 2D (COSY, ROESY, HSQC and HMBC) experiments, 
comparison with data reported in the literature and chemical correlations. 
The isolated compounds were assayed for their reversal activity against a 
multidrug-resistant Leishmania tropica line. Compound 1 showed moderate 
activity with a growth inhibition of 82% at 30 μM. 
_____________________________________________________________ 
  Sudanese medicine used for the treatment of tumors, dysentery and 
snake bites, whereas, M. ilicifolia has been used for anticancer and 
contraception Introduction. - Medicinal plants play an important role in 
public health, especially in developing countries. In fact, more than a 
quarter of all the medicines used in the world today contain ingredients 
derived from plants [1]. Drug resistance has emerged in the last few years as 
one of the major impediments for the successful treatment of cancer and 
diseases caused by protozoan parasites like Leishmania spp. One of the 
most important drug resistance mechanisms is the overexpression of the 
ABC efflux pump P-glycoprotein (Pgp) and other related drug transporters. 
Therefore, Pgp-related proteins are promising targets for anti-infectious 
therapy [2].  
Maytenus species (Celastraceae family) are used in traditional 
medicine around the world. The stem bark of M. senegalensis is a traditional 
as a medicinal folk plant in South America. In the sub-Andean rain forest, a 
plant known as “chuchuhuasha” (a plant confirmed as belonging to the 
genus Maytenus) is used for the treatment of rheumatism, asthma, fertility-
regulating agent, to treat stomach problems and skin cancer [3].  
Maytenus chubutensis (chaurilla) and M. magellanica (maitén negro) 
are found in the Antarctica Andean woodland covering parts of Argentina 
and Chile. We have reported previously on the roots of both species, the 
isolation of dihydro-β-agarofuran sesquiterpenes [4], potent and specific 
modulators of Leishmania Pgp-like transporter [5], and triterpene dimers 
[6]. 
This paper reports the isolation of one phenolic nor-triterpene (1) 
and one nor-ent-kaurene diterpene (2), along with four known compounds 
from the root bark extracts of M. chubutensis and M. magellanica. Their 
structures were elucidated by comprehensive NMR analyses and 
spectrometric methods. The known compounds were identified by 
comparison with authentic samples or reported data. In our program for 
developing bioactive natural products from the Celastraceae as reversal 
agents of the multidrug resistance (MDR) phenotype, we have carried out 
the biological evaluation of the isolated compounds as potential modulators 
of the MDR in a Leishmania tropica line overexpressing a Pgp-like 
transporter.  
 
 Results and Discussion. - Repeated chromatography of the 
hexanes/Et2O (1:1) extracts of the root bark of M. chubutensis and M. 
magellanica afforded the new compounds 1 and 2, in addition to the known 
triterpenes 28-methyl ester of the acid 3,4-secolupa-4(23):20(29)-dien-3-oic 
(3), obtained for the first time as a natural product [7], 6-oxo-pristimerol (4) 
[8], pristimerin (5) [9] and the diterpene (-)-pimara-9(11), 15-dien-19-ol (6) 
[10]. 
3-O-Methyl-6-oxo-pristimerol (1), obtained as a pale yellow lacquer, 
was shown to have the molecular formula C31H42O5 by analysis of its 
HREIMS and 13C NMR data. The IR spectrum exhibited absorption bands 
at 3518 cm-1 (hydroxyl group), 1727 cm-1 (ester carbonyl), 1642 cm-1 (α,β-
unsaturated carbonyl) and 1571 and 756 cm-1 (aromatic ring). This was 
confirmed by its UV spectrum, showing absorption maxima at 239 and 303 
nm, characteristic of an aromatic ring and a conjugated ketone, respectively. 
The 1H NMR spectrum of 1 (Table 1), showed signals for six methyls at 
δ(H) 2.66,  1.52,  1.29,  1.17, 1.09 and 0.57, attributed to H3-23, H3-25, H3-
26, H3-30, H3-28 and H3-27, respectively. The phenolic moiety was 
characterized by two singlet protons at δ(H) 6.24 and 6.95, which were 
assigned to a proton in α position to a conjugated ketone and an aromatic 
proton, respectively. The unusual downfield chemical shift at δ(H) 2.66, 
assigned to the methyl group attached to a sp2 carbon (H3-23), is due to 
anisotropic effects produced by its periplanar position with the carbonyl 
group located on C-6. Further oxygenated functional groups were attributed 
to two methoxyl groups at δ(H) 3.53 and 3.79 and one phenolic proton at 
δ(H) 6.08 (interchangeable with D2O). The 13C NMR and DEPT 
experiments (Table 1) showed signals for 31 carbons. The most significant 
being those at δ(C) 187.2 and 178.8, attributed to C-6 and C-29, 
respectively, and signals for two sp3 carbons belonging to methoxyl groups 
(δ  61.1 and 51.5). These data suggested that 1 was a phenolic nor-triterpene 
of pristimerin-type.  
The full assignments and connectivities were based on COSY, 
HSQC, HMBC and ROESY experiments and comparison with published 
data for 6-oxo-pristimerol [8]. The long-range correlation observed in the 
HMBC spectrum (Figure) from the singlet at δ(H) 3.79 (3H) to the aromatic 
carbon at δ(C) 132.9 (C-3) confirmed the attachment of the methoxyl group 
at C-3. The ester group was located at C-29 by correlations of the methyl 
group at δ(H) 1.17 (C-30) and the methoxyl group at δ(H) 3.53 with the 
carbonyl carbon of the ester group at δ(C) 178.8 (C-29). Furthermore, this 
was confirmed by the ROE effects observed between the signals at δ(H) 
3.79 (3H, s, OMe) and δ(H) 2.66 (3H, s, H3-23) and between the signals at 
δ(H) 3.53 (3H, s, OMe) and δ(H) 0.57 (3H, s, H3-27) in a ROESY 
experiment. All these data allowed the unequivocal assignment of the 
structure of 1 as 3-O-methyl-6-oxo-pristimerol, which was further 
confirmed by chemical correlations with 6-oxo-pristimerol (4) [8]. Thus, 
when compounds 1 and 4 were methylated with dimethyl sulphate in the 
usual way, they afforded the same compound, 2,3-O-dimethyl-6-
oxopristimerol [11]. 
Compound 2 was isolated as a colorless lacquer with the molecular 
formula C19H28O2 determined by HREIMS and 13C NMR analysis. The 
presence of carboxylic acid functionality was evident from IR absorptions 
(370-2700 and 1703 cm-1). The 13C NMR spectrum exhibited 19 carbons, 
attributable to one methyl, ten methylenes, four methines and four 
quaternary carbons, indicating a nor-diterpene structure. The most 
significant were three down-field signals at δ(C) 103.1 (t), 155.6 (s) and 
182.0 (s) attributed to two carbons of an exocyclic double bond and one 
carboxylic acid, respectively. Comparison with related kauranoid diterpenes 
suggested that 2 possess an ent-kaurane-type skeleton with a carboxylic acid 
located at C-17 [12]. The 1H NMR spectrum revealed the presence of a 
tertiary methyl at δ(H) 0.97 (3H, s, Me-20) and a methylene group at δ(H) 
4.75 and 4.80 (each 1H, br s, 2H-19). The full assignments were made by 
careful analysis of 1D and 2D spectra. The connectivity of the units and the 
position of the groups were determined from an HMBC experiment 
(Figure). Thus, the long-range correlation observed between the proton 
signals at δ(H) 2.33 (H-13), 2.65 (H-16) and 1.44, 1.57 (H-15) and the 
carbon signal at δ(C) 182.0 (C-17) supported the location of the carboxylic 
acid group at C-17. Moreover, cross-peak between the proton signals at 
δ(H) 4.75 and 4.80 (H2-19) and the carbon signals at δ(C) 155.6 (C-4), 49.1 
(C-3) and 48.7 (C-5) located the double bond between C-4 and C-18. The 
signal at δ(H) 0.97 (H3-20) was correlated with the carbons at δ(C) 38.8 (C-
1), 48.7 (C-5), 53.5 (C-9) and δ(C) 38.1 (C-10). All these data established 
the structure of compound 2 as 18-nor-ent-kaur-4(19)-en-17-oic acid. 
The known seco lupane triterpene 28-methyl ester of the acid 3,4-
secolupa-4(23):20(29)-dien-3-oic (3) was isolated from a natural source for 
the first time, and its 1H and 13C NMR (Table 1) assignments, not previously 
reported, were achieved by 1D and 2D NMR techniques. 
Biological Activity. In the search for reversal agents of MDR 
phenotype from Celastraceae, the isolated compounds 1, 2, 4 and 6 were 
assayed against a MDR Leishmania tropica overexpressing a Pgp-like 
transporter, in order to determine their ability to revert the resistance 
phenotype. The results showed that only compound 1 had a moderate 
activity with a growth inhibition of 82% at 30 μM (Table 2).  
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Experimental part 
 General. Column chromatography (CC): Silica gel 60 (SiO2; 15-40 and 63-200 
µm, Macherey-Nagel), TLC: Polygram Sil G/UV254 (Macherey-Nagel), HPTLC-Platten: 
Nano-Sil 20 UV254 (Macherey-Nagel), Sephadex LH-20 (Pharmacia Biotech). The spots 
were visualized by UV light and heating silica gel plates sprayed with H2O-H2SO4-AcH 
(1:4:20). Optical rotations: Perkin Elmer 241 automatic polarimeter, the [α]D values are 
given in units of 10-1 deg cm2 g-1. UV Spectra: JASCO V-560. IR Spectra: Bruker IFS 55 
spectrophotometer. 1H (400 MHz) and 13C (100 MHz) NMR and 2D-NMR Spectra: Bruker 
Avance 400 spectrometer; chemical shifts δ are given in ppm and coupling constants in Hz, 
with residual CDCl3 as internal reference (δH 7.26, δC 77.0); DEPT COSY, ROESY, HSQC, 
and HMBC experiments were carried out with the pulse sequences given by Bruker. EIMS 
and HREIMS: Micromass Autospec spectrometer in m/z. All solvents used were analytical 
grade from Panreac. Reagents were purchased from Sigma Aldrich and used without further 
purification. 
Plant Material. Maytenus chubutensis (Speg.) Lourt., O'Don. et Sleum was 
collected in December 2004, in the Séptima Región in Talca province, Chile. The plant was 
identified by Prof. José San Martín. Maytenus magellanica (Lam) Hook. f. was collected in 
December 2003, in the Novena Región in Temuca province, on the slopes of the volcano 
Osorno in Chile and identified by Prof. Sebastián Teyller. The voucher specimens are 93-
5200 and 93-5342-A, respectively, on file with the Facultad de Ciencias, Universidad de 
Chile, Chile. 
Extraction and Isolation. Air dried, chopped root bark of M. chubutensis (390 g) 
was extracted with hexanes-Et2O (1:1) in a Soxhlet apparatus. Evaporation to dryness under 
reduced pressure gave 7.8 g of residue, which was fractionated by vacuum liquid 
chromatography on silica gel and eluted with hexanes (0.5 l) followed by a gradient of 
hexanes-EtOAc up to 100% EtOAc (0.5 l of each solvent mixture). Fifty-two fractions were 
collected and combined on the basis of their TLC profiles to afford nine main fractions (A-
I). Further flash chromatography of fraction D (492 mg) on silica gel, using a gradient 
elution from hexanes-Et2O 20% up to 100% Et2O, yielded six fractions (D1-D6) after TLC 
analysis. Compound 1 (4.1 mg) was obtained by purification of fraction D2 (14 mg) by 
preparative HPTLC, using hexanes-Me2CO (8:2) as eluent. The rest of the fractions were 
subjected to preparative TLC, using a mixture of hexanes-Me2CO, hexanes-Et2O or 
hexanes-EtOAc affording 6-oxo-pristimerol (4) and pristimerin (5), which were identified 
by means of spectroscopic methods and comparison with authentic samples or reported 
data.  
The root bark of M. magellanica (570 g) was extracted with n-hexane-Et2O (1:1) 
in a Soxhlet apparatus. Evaporation to dryness under reduced pressure gave 13.5 g of 
residue. The residue was fractionated by CC over Sephadex LH-20 (8 x 70 cm) eluting with 
hexanes-CHCl3-MeOH (2:1:1) to afford 55 fractions which were combined in eleven 
fractions (A-K) on the basis of their TLC profiles. Further flash chromatography of 
fractions E (180 mg) and F (137 mg) on silica gel, using a gradient elution from hexanes-
EtOAc 20% up to 100% EtOAc, yielded eight fractions (1-8) after TLC analysis. 
Compound 2 (8.2 mg) was isolated from fraction E2 (15.1 mg) after purification by 
preparative TLC, using hexanes-Me2CO (7:3) as eluent. Compound 3 (7.3 mg) was 
obtained by purification of fraction F3 (14.8 mg) by preparative TLC, using hexanes-
Me2CO (6:4) as eluent. The rest of the fractions were subjected to preparative TLC using 
mixtures of hexanes-Me2CO, hexanes-Et2O or hexanes-EtOAc affording: 6-oxo-pristimerol 
(4), pristimerin (5) and (-)-pimara-9(11)-15-dien-19-ol (6), which were identified by 
spectroscopic methods and comparison with authentic samples or reported data.  
3-O-Methyl-6-oxo-pristimerol (1). Pale yellow lacquer; [α]D25: +1.9 (c = 0.19, 
CHCl3). UV (EtOH): 239 (4.2), 303 (4.4). IR (film): 3518, 2930, 2870, 1727, 1642, 1571, 
1480, 1454, 1313, 1262, 1100, 1027, 756. 1H (400 MHz, CDCl3) and 13C (100 MHz, 
CDCl3) NMR data: Table 1. EI-MS: 494 (M+, 100), 479 (29), 435 (5), 299 (7), 232 (53), 
203 (14), 105 (9). HR-EI-MS: 494.3023 (M+), C31H42O5; calc. 494.3032. 
Methylation of compounds 1 and 4. To a solution of 3-O-methyl-6-oxo-pristimerol 
(1, 2.2 mg) or 6-oxo-pristimerol (4, 2.9 mg) in acetone (1 ml), K2CO3 (9 mg) and dimethyl 
sulphate (20 μl) were added. The reaction was stirred for 14 h at room temperature. The 
reaction mixture was concentrated to yield an oil, which was purified by preparative TLC 
using a mixture of hexanes-EtOAc (8:2) as eluent to afford compound 2,3-O-dimethyl-6-
oxo-pristimerol (1.9 mg and 2.3 mg, respectively). 
18-nor-ent-Kaur-4(19)-en-17-oic acid (2). Colorless lacquer; [α]D25: -23.8 (c = 
0.82, CHCl3). IR (film): 3700-2700, 2925, 2855, 1703, 1450, 1005. 1H NMR (400 MHz, 
CDCl3): 0.86, 1.84 (2H, H-1), 0.97 (s, 3H, H-20), 1.12 (1H, H-9), 1.13, 1.99 (m, 2H, H-14), 
1.32 (m, 1H, H-5), 1.40 (2H, H-12), 1.44, 1.57 (2H, H-15), 1.50, 1.92 (2H, H-2), 1.51, 1.63 
(2H, H-7), 1.58 (2H, H-6), 1.64 (2H, H-11), 2.03 (m, 2H, H-3), 2.33 (m, 1H, H-13), 2.65 (br 
s, 1H, H-16), 4.75 (br s, 1H, H-19), 4.80 (br s, 1H, H-19). 13C NMR (100 MHz, CDCl3): 
15.0 (q, C(20)), 18.1 (t, C(11)), 20.2 (t, C(6)), 24.1 (t, C(12)), 30.2 (t, C(2)); 33.0 (t, C(7)), 
38.1 (s, C(10)), 38.8 (t, C(1)), 39.7 (t, C(15)), 40.0 (t, C(14)), 43.8 (d, C(16)), 44.1 (d, 
C(13)), 44.4 (s, C(8)), 48.7 (d, C(5)), 49.1 (t, C(3)), 53.5 (d, C(9)), 103.1 (t, C(19)), 155.6 
(s, C(4)), 182.0 (s, C(17)). EI-MS: 288 (M+, 69), 273 (76), 255 (18), 245 (100), 229 (64), 
199 (79), 149 (40), 117 (41), 91 (66), 55 (54). HR-EI-MS: 288.2110 (M+), C19H28O2; calc. 
288.2089. 
28-Methyl ester of the acid-3,4-secolupa-4(23):20(29)-dien-3-oic (3). Colorless 
lacquer; [α]D25: +15.3º (c = 0.73, CHCl3). IR (CHCl3): 3520-2637, 2947, 2869, 1708, 1641, 
1456, 1215, 1156, 890, 757. 1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data: 
Table 1. EI-MS: 484 (M+, 10), 425 (12), 403 (47), 343 (81), 273 (20), 248 (19), 201 (35), 
189 (46), 175 (57), 133 (43), 121 (55), 107 (70), 95 (85), 81 (82), 69 (84), 55 (100). HR-EI-
MS: 484.3550 (M+), C31H48O4; calc. 288.3553.  
In vitro assays for MDR reversion in Leishmania. Compounds 1, 2, 4 and 6 have 
been tested for efficacy as potential modulators of Pgp in a Leishmania tropica line 
according to an established protocol [13]. Briefly, we used a wild-type of L. tropica (LCR 
strain) and a MDR L. tropica line highly resistant to daunomycin (DNM), which was 
maintained in the presence of 150 μM DNM. This resistant line overexpress a Pgp-like 
transporter and possesses a MDR phenotype similar to that of tumor cells, with a cross 
resistance to several unrelated drugs. Promastigote forms were grown at 28 ºC in RPMI 
1640-modified medium and supplemented with 20% inactivated foetal bovine serum. The 
reversal activity of isolated compounds was determined by the calculation of parasite 
growth inhibition using the MTT colorimetric assay after 72 h incubation at 28 ºC in 
presence of increasing concentrations of compounds. 
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Table 1. 1H and 13C NMR Data of compounds 1 and 3. Recorded at 400/100 
MHz, respectively; in CDCl3, δ in ppm, J in Hz. Assignment of 13C NMR 
data were made with the aid of DEPT, HSQC and HMBC experiments. 
Position  1 3
  δH δC  δH δC 
1  6.95 s 109.1 d  1.61 33.9 t 
2   144.2 s  2.37, 2.22 28.1 t 
3  OH-3, 6.08 s 132.9 s   179.1 s 
4   132.0 s   147.5 s 
5   154.9 s  1.92 50.4 d 
6   187.2 s  1.39, 1.94 24.5 t 
7  6.24 s 126.1 d  1.48* 32.8 t 
8   151.9 s   40.9 s 
9   40.4 s  1.48* 40.4 d 
10   171.2 s   39.2 s 
11  1.94, 2.21 34.0 t  1.37, 1.48 21.4 t 
12  1.66, 1.72 29.8 t  1.05, 1.79 25.4 t 
13   38.9 s  2.25 38.3 d 
14   44.7 s   42.8 s 
15  1.40, 1.80 28.5 t  1.49, 1.93 30.6 t 
16  1.50, 1.80 36.4 t  1.47, 2.25 32.1 t 
17   30.8 s   56.5 s 
18  1.58  44.3 d  1.60 49.4 d 
19  2.91 d (15.9), 
1.66 
30.5 t  2.99 dt (4.9, 10.8) 46.9 d 
20   40.3 s   150.4 s 
21  2.19, 1.37 29.7 t  1.40 29.7 t 
22  2.04, 0.97 34.8 t  1.44, 1.90 36.9 t 
23  2.66 s 14.7 q  4.65, 4.84 br s 113.4 t 
24     1.72 s 23.2 q 
25  1.52 s 37.6 q  0.83 s 20.1 q 
26  1.29 s 20.8 q  0.97 s 15.9 q 
27  0.57 s 18.3 q  1.00 s 14.6 q 
28  1.09 s 31.6 q   176.6 s 
29   178.8 s  4.61, 4.73 br s 109.7 t 
30  1.17 s 32.7 q  1.68 19.3 q 
OMe-3  3.79 s 61.1 q    
OMe-29  3.53 s 51.5 q    
OMe-28     3.66 s 51.3 q 
* Overlapping signals. 
 
 
 
 
 
 
Table 2. Reversal activity in an MDR L. tropica linea. 
 30 μM 15 μM 7.5 μM 3.75 μM 
Compd  Wt MDR Wt MDR Wt MDR Wt MDR 
1 38 ± 6 82 ± 7 8 ± 5 44 ± 1 1 ± 1 25 ± 4 0 ± 0 13 ± 0 
2 2 ± 2 2 ± 3 6 ± 5 7 ± 5 4 ± 3 1 ± 1 0 ± 0 0 ± 0 
4 11 ± 8 3 ± 3 6 ± 5 0 ± 0 4 ± 5 0 ± 0 4 ± 4 0 ± 0 
6 3 ± 4 23 ± 8 2 ± 2 5 ± 2 0 ± 0 1 ± 1 0 ± 0 0 ± 0 
a) Wild-type (Wt) and MDR parasites were exposed to compounds 1, 2, 4 and 6, 
in the absence or presence of 150 μΜ DNM, respectively. Results are expressed 
as percentage growth inhibition relative to control growth in the absence of 
compounds. Data shown are the average of three independent experiments ± SD. 
 
 
Figure: Key HMBC correlations of compound 1-3. 
